AGBK AGBK
Company Profile ↓Company Overview
AGBK (AGBK) is a publicly traded company listed on with a market capitalization of $1.10B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 31.7%, reflecting efficient use of shareholder capital.
Net profit has compounded at 83.2% per year over the last five years.
Revenue has grown at a 40.5% CAGR over the past five years.
Trades at an undemanding P/E of 1.1.
Maintains a net profit margin of 16.1%.
Recent Developments
- Dec 2025 Revenue of $6.47B (+34.7% YoY); net profit $1.04B.
- Trailing 12 Months Year-on-year growth — revenue +34.7%, earnings +31.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 40.5%, profit CAGR 83.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 40.52% |
| 1 Year: | 34.72% |
Compounded Profit Growth
| 5 Years: | 83.17% |
| 1 Year: | 31.20% |
Stock Price Performance
| 1 Year: | -36.00% |
| 6 Months: | - |
| 3 Months: | +4.72% |
| 1 Month: | -2.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)45.90 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 31.7%.
- Compounding revenue at 40.5% over 5 years.
- Profit CAGR of 83.2% over 5 years.
CONS
- Trading 42.7% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 1.38B | 1.47B | 1.64B | 1.37B |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | - | - | - | - |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 743.15M | 951.31M | 1.32B | 1.63B |
| Pretax Income | 242.72M | 511.67M | 238.10M | 216.07M |
| Tax Provision | 45.57M | 155.20M | 23.18M | 29.54M |
| Net Income | 195.21M | 349.98M | 214.92M | 186.53M |
| Diluted EPS | - | 2.19 | 1.34 | 1.39 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 2.33B | 3.20B | 4.80B | 6.47B |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | - | - | - | - |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 991.64M | 1.78B | 2.47B | 4.23B |
| Pretax Income | 244.24M | 581.63M | 1.04B | 1.34B |
| Tax Provision | 72.92M | 155.58M | 246.66M | 290.21M |
| Net Income | 168.88M | 421.99M | 791.01M | 1.04B |
| Diluted EPS | 1.06 | 2.64 | 4.95 | 6.49 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | 19.36B | 29.51B | 47.76B |
| Current Assets | - | - | - |
| Cash & Equivalents | 353.68M | 454.18M | 1.11B |
| Inventory | - | - | - |
| Receivables | 125.16M | 254.92M | 378.22M |
| Total Liabilities | 18.05B | 27.04B | 44.48B |
| Current Liabilities | - | - | - |
| Long Term Debt | 363.94M | 759.24M | 1.21B |
| Total Debt | 570.69M | 1.26B | 1.67B |
| Total Equity | 1.31B | 2.36B | 3.28B |
| Shares Outstanding | 159.93M | 159.93M | 159.93M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 610.18M | -33.32M | 487.04M | -409.62M |
| Investing Cash Flow | -98.78M | -78.00M | -107.80M | -162.39M |
| Financing Cash Flow | -73.87M | -69.75M | 572.78M | 19.88M |
| Capital Expenditure | -98.78M | -80.34M | -107.80M | -162.39M |
| Free Cash Flow | 511.40M | -113.66M | 379.24M | -572.01M |
| Net Change in Cash | 437.54M | -181.07M | 952.02M | -552.13M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 7.2% | 13.2% | 16.5% | 16.1% |
| ROE % | - | 32.3% | 33.5% | 31.7% |
| ROCE % | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AGBK
Agi+ Offers Health, Home and Pet Benefits; Savings Up to R$1,500/Year - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOQXE5U3dUX3VKX1hYR2UyMnJSWGgxR1gyREwyZGlMZnlzY0I2bjN3WEdRVHZHUDRSZmwyR3hXeU82N2QwNnRjRC13RkIzLUM3N3JxdTRvZEs0UUY5bWdHQzFxV0M1OWNhVEpGNTdWanVNTHNtdTNILWJNZF83Tjl5dHpOMzdrVXZKVTk3Yz…
AGI Inc's (NYSE:AGBK) Lock-Up Period To End on August 10th - MarketBeat
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQbExKb1hUSU1vVFBKdUt0d1BjVXpCc0l3RDBfRnpoVGtpOXh3S3FBUzVmV3ZydG9DZjVidklCVmg4UjdzdDNlN3cwcGpYTHhJME5EOU5jZ29tZy1HdGFiUGNqSnZqVVdDZHdnX0RMR3c0RElza3J0SUw0LWtzMjRENFByQ1gwbFdhYjRCNk…
Price to earnings forward of AGI Inc – NYSE:AGBK - TradingView
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOVm1rRlE3WTB4Q3g0OE4zRWtjdDM4ejZwdkZrLXhlYjh1MVZBTXVEYy1wcTZiQkVCMVVFTVNSRXRnb09OX0dnOUYzelA5Qy1WLTJwUW1BenVDd0hGWTFBSk4zYUlmWkdxdzdXVkQ3amM2Z3QtWkxlSlpTcVZZRGJKajBSRW9XaTJwM2ZES2…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1vUmlPS3NHYnpBRll4Y3BHQm1hRHJFc09iVW1zVEVIcjM1b2hHc2N0LXlFcUp6anFJNU5KUmpzd3kwY3FSMG9yVndsak55eGJ4?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Assessing AGI (AGBK) Valuation After Recent Share Price Weakness And Discounted Earnings Multiple - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPMFRmZjQzaV9rZVp5bDZRVTRrREptakx6RzU2UWNSTnF3R0N0V0ZJWV8wMUVLbEVfUTctN1lnY3JIOHNLdlowS2Q5VTRxU1hMeXRiaEt0WU5ETk9jc29CUWFLX1ZGT1RyU1BnZF9oYklFS3k5WjZPUzFsdHBXWWtsVTJnUG92ampTNGo1dH…
Agibank’s New App Lets Customers Invest With Daily Liquidity - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQM1g5WE8tb0k4MXlGSlFxTVd6SmRRTmJaSFdyR1NQeUp6U2hIbk45dWZVSzk3aEhKY1YxTXNHV2xPY3U0QmFMSTJ0bjBHZ1c0S2VQRkxhZTJiSWtQWnVTTThmZHpsQ0FOZFJHQ3FFb2V0d19GcXBTbmFzb3JVRXpEVFFENVBGc0h5aHdrTz…
AGBK — Frequently Asked Questions
What is the current share price of AGBK?
As of 2026-08-05 17:25 PDT, AGBK trades at $6.88 on NASDAQ/NYSE. Its 52-week range is $6.37 to $12.00.
What is the market capitalisation of AGBK?
AGBK has a market capitalisation of $1.10B on NASDAQ/NYSE.
What is the P/E ratio of AGBK?
AGBK trades at a trailing price-to-earnings (P/E) ratio of 1.06. Its price-to-book (P/B) ratio is 0.34.
What is the return on equity (ROE) of AGBK?
AGBK has a return on equity (ROE) of 31.67%.
Is AGBK a good stock to buy?
This page provides a data-driven analysis of AGBK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.